Motivational Interviewing and Air Cleaners for Smokers with COPD (MOVE): A Randomized, Double-Blind, Placebo-Controlled Trial

Study Overview

Chronic obstructive pulmonary disease, or COPD, is a long-term lung condition that makes breathing difficult and is commonly linked to cigarette smoking. People with COPD often experience chronic cough, shortness of breath, mucus production, and flare-ups that can lead to emergency visits or hospitalization. While quitting smoking remains the most effective way to slow disease progression, many patients continue to smoke, which makes symptom control even more challenging.

This randomized, double-blind, placebo-controlled trial tested whether improving indoor air quality could help smokers with moderate-to-severe COPD feel and function better. The intervention combined two strategies: portable high-efficiency particulate air cleaners to reduce indoor particulate matter, and motivational interviewing to help reduce secondhand smoke exposure. Researchers compared this active approach with sham air cleaners and no motivational interviewing.

Why Indoor Air Quality Matters in COPD

Indoor air pollution is an often overlooked trigger for respiratory symptoms. Fine particles, such as PM2.5, can come from tobacco smoke, cooking, heating, dust, and outdoor pollution that enters the home. These particles irritate the airways and may worsen inflammation, leading to more cough, wheeze, breathlessness, and poor quality of life.

Secondhand smoke is another major concern. Even when a person is a current smoker, exposure to smoke from other people can add to the overall inhaled toxic burden. In theory, reducing both particulate matter and secondhand smoke in the home could improve symptoms and reduce respiratory stress, even if the person continues to smoke.

How the Trial Was Designed

The study enrolled current smokers with moderate-to-severe COPD. A total of 121 participants were randomized, and 99 completed the trial. Participants were assigned to one of two groups:

The active intervention group received portable high-efficiency particulate air cleaners that were actually functioning, along with motivational interviewing focused on reducing particulate exposure and secondhand smoke.

The control group received sham air cleaners that looked similar but did not provide meaningful air filtration, and they did not receive the motivational interviewing component.

The double-blind design meant that participants and researchers were protected from bias as much as possible regarding which air cleaners were active and which were sham. The main outcome was the change in the Saint George’s Respiratory Questionnaire score over 6 months, a validated measure of health-related quality of life in people with chronic lung disease. Secondary outcomes included respiratory symptoms, flare-up risk, and lung function.

Main Findings

The active intervention successfully reduced indoor particulate matter levels compared with the control condition. However, it did not significantly reduce indoor secondhand smoke exposure, suggesting that the air cleaners were effective for particles but that smoke exposure remained difficult to change through home-based counseling alone.

Despite that limitation, people in the active intervention arm experienced a clinically meaningful and statistically significant improvement in total Saint George’s Respiratory Questionnaire score compared with the control group. The reported difference was ß -4.4, with a 95% confidence interval from -8.2 to -0.5, and a P value of .025. In practical terms, this suggests that participants felt better overall in ways that were likely noticeable in daily life.

Secondary analyses also showed significant improvement in respiratory symptoms, especially dyspnea and cough, as well as in health status measures assessed by the COPD Assessment Test and the Clinical COPD Questionnaire. These results support the idea that improving the home environment can make breathing easier and improve day-to-day well-being.

However, not every outcome changed. There was no significant difference between the groups in forced expiratory volume in 1 second, or FEV1, which is a common measure of lung function. There was also no clear difference in sputum symptoms or in the odds of COPD exacerbations. This suggests that the intervention improved symptoms and quality of life more than it altered underlying lung mechanics or short-term flare-up frequency.

What the Results Mean

This study is important because it shows that an environmental intervention may help smokers with COPD, even when smoking continues. That is notable, since most COPD interventions focus on medication, smoking cessation, or pulmonary rehabilitation. Portable air cleaners are relatively low-risk and easy to use, and they may provide a useful extra layer of symptom relief at home.

The findings also suggest that particulate matter reduction may be the main mechanism behind the benefit. In homes where smoking continues, air cleaners can lower concentrations of suspended particles from tobacco smoke and other sources. Even if they cannot remove all harmful smoke gases or fully eliminate secondhand smoke exposure, reducing particle load may still ease airway irritation and improve symptoms.

The motivational interviewing component was intended to help participants reduce secondhand smoke exposure through behavior change. Motivational interviewing is a counseling technique that helps people explore ambivalence and strengthen personal motivation for change. Although it did not significantly lower secondhand smoke exposure in this trial, it may still have supported broader awareness and engagement around home air quality.

Clinical and Public Health Implications

For clinicians, this trial offers a practical message: while smoking cessation remains the priority, home air quality interventions may provide meaningful symptom relief for patients with COPD who are unable or unwilling to quit right away. This is especially relevant for patients who spend substantial time indoors or live in environments with multiple sources of indoor pollution.

From a public health perspective, the study highlights the importance of the home as a respiratory exposure setting. COPD management does not end with inhalers and clinic visits. Environmental supports, including cleaner indoor air, may help reduce symptom burden and improve quality of life.

At the same time, the trial should not be interpreted as a substitute for smoking cessation. Continued smoking remains the strongest modifiable risk factor for COPD progression, exacerbations, cardiovascular disease, and premature death. Air cleaners can help, but they do not remove the broader harms of tobacco use.

Strengths and Limitations

One strength of the study is its randomized, double-blind, placebo-controlled design, which gives the findings more credibility than an uncontrolled or observational study would. Another strength is that the intervention was feasible and measured real-world outcomes that matter to patients, such as symptom burden and quality of life.

There are also limitations. The sample size was modest, and not all randomized participants completed the study. The intervention improved particle levels, but it did not significantly reduce secondhand smoke exposure, which may have limited the size of the effect. Lung function did not improve, and the follow-up period may have been too short to detect changes in exacerbation frequency or slower disease-related outcomes.

In addition, the study focused on smokers with COPD, so the findings may not apply to nonsmokers with COPD, people with milder disease, or households with different environmental exposures. Real-world benefit may also depend on how consistently air cleaners are used and how much pollution is present in the home.

Bottom Line

In this trial, portable high-efficiency particulate air cleaners, combined with motivational interviewing, improved indoor air quality and led to better respiratory symptoms and quality of life in current smokers with COPD. The benefit appears to be driven mainly by reduced particulate matter exposure.

The study offers a promising, practical adjunct to standard COPD care, especially for patients who continue to smoke. It reinforces a simple but important idea: breathing cleaner air at home can matter, even when other risk factors remain difficult to change.